Quiz 9, Chapter 9

Question 1

Which area of drug R&D has seen the largest cost increases?

Answer 1

Clinical trials.

Question 2

On average, how long does it take for a new drug to be developed (i.e. from the discovery of the initial compound to FDA approval)?

Answer 2

10-15 years.

Question 3

Which of the following agencies is industry-based (i.e. run mainly by the companies themselves)? - a) Drug Enforcement Administration, b) European Medicines Agency, c) Pharmaceutical Research and Manufacturers of America (PhRMA), or d) the FDA?

Answer 3

PhRMA.

Question 4

Growing demand in the medical community for more complex data about pharmaceuticals has simplified the pharmaceutical R&D process?

Answer 4

False.

Question 5

The landmark FDA Modernization Act of 1997 was a major step forward in enabling safe and effective new drugs and biologics to be made available sooner to patients.

Answer 5

True.

Question 6

Which type system is the best way to deliver healthcare?

Answer 6

A market-based system.

Question 7

How would increased pharmaceutical price controls affect the U.S. healthcare system?

Answer 7

Increased price controls would stifle innovation.

Question 8

Which invests a greater percentage of sales in research than the biotech sector - a) aerospace, b) communications, or c) electronics?

Answer 8

None of these.

Question 9

What was the intent of the Bayh-Dole Act and the Stevenson-Wydler Technology Innovation Act?

Answer 9

To hasten the commercialization of technologies that otherwise might not be used.

Question 10

What did the G10 Medicines Group recently report about the pharmaceutical industry in the European Union (EU)?

Answer 10

There is poor collaboration between publicly- and privately-funded research centers.